<?xml version="1.0" encoding="UTF-8"?>
<ref id="B99-vaccines-07-00053">
 <label>99.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Gaelings</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Soderholm</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Belanov</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Nandania</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Nyman</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Matikainen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Anders</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Velagapudi</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kainov</surname>
    <given-names>D.E.</given-names>
   </name>
  </person-group>
  <article-title>JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses</article-title>
  <source>Antivir. Res.</source>
  <year>2016</year>
  <volume>133</volume>
  <fpage>23</fpage>
  <lpage>31</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.07.008</pub-id>
  <?supplied-pmid 27451344?>
  <pub-id pub-id-type="pmid">27451344</pub-id>
 </element-citation>
</ref>
